more_reports

Prevail Therapeutics Inc.

PRVL:NASDAQ

Prevail Therapeutics is developing disease-modifying gene therapies for patients with Parkinson's disease and other neurodegenerative disorders.

streetwise book logo Streetwise Company Fact Sheet

2026/1/14 1:11:02

(PRVL:NASDAQ)